Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-Controlled Study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Clinical Therapeutics

Topics

Medicine

Pathology

Internal Medicine

Endocrinology

Surgery

Show all topics

DOI

10.1016/j.clinthera.2024.06.023

License

CC-BY-NC-ND